Emergent Biosolutions's total assets for Q3 2024 were $1.48B, a decrease of -2.36% from the previous quarter. EBS total liabilities were $969.40M for the fiscal quarter, a -14.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.